Global Central Vascular Access Devices Market Size By Type (Peripherally inserted central catheters (PICC), Tunneled catheters), By Application (Drug administration, Fluid and nutrition administration...

The Global Central Vascular Access Devices Market was valued at USD 4.1 billion in 2023 and is projected to reach USD 6.9 billion by 2031, expanding at a CAGR of 6.2% during the forecast period from 2023 to 2031. Central vascular access devices (CVADs) play a crucial role in modern healthcare, providing reliable access to the central venous system for the administration of medications, fluids, parenteral nutrition, and for blood sampling. The market is primarily driven by the increasing prevalence of chronic illnesses such as cancer and kidney disease, rising demand for long-term intravenous therapies, and advancements in catheter technology that improve safety and reduce infection risks.

Drivers:

Rising Incidence of Chronic Diseases

The increasing burden of chronic illnesses such as cancer, end-stage renal disease, and cardiovascular disorders is significantly driving the demand for long-term vascular access solutions. CVADs offer a stable and efficient route for drug delivery and blood monitoring, especially for oncology and dialysis patients.

Technological Advancements in Device Design

Innovations such as antimicrobial-coated catheters, tunneled devices with lower infection risks, and power-injectable ports are enhancing patient outcomes and boosting adoption rates, particularly in high-risk populations.

Growing Surgical and Critical Care Procedures

The surge in surgical interventions and ICU admissions requiring intensive monitoring and fluid management is leading to increased use of CVADs in hospital settings worldwide.

Restraints:

Complications Associated with CVADs

Risks such as catheter-related bloodstream infections (CRBSIs), thrombosis, and mechanical complications may hinder adoption and raise concerns among healthcare professionals.

High Cost of Insertion and Maintenance

The placement and management of CVADs require skilled healthcare professionals, imaging guidance, and ongoing maintenance, resulting in higher healthcare costs, particularly in resource-limited settings.

Opportunity:

Rising Demand from Emerging Markets

Emerging economies across Asia-Pacific and Latin America are experiencing rapid growth in healthcare infrastructure and spending. Increasing awareness and government initiatives to improve access to advanced treatment options provide a fertile ground for CVAD market expansion.

Home-Based Infusion Therapy Trends

The shift toward home-based care, particularly for patients requiring long-term treatment such as chemotherapy or parenteral nutrition, opens new opportunities for portable and user-friendly vascular access solutions.

Market by System Type Insights:

The Peripherally Inserted Central Catheter (PICC) segment led the market in 2023. Its minimally invasive nature, lower complication rates, and suitability for both hospital and outpatient care make PICCs the preferred choice among clinicians. However, Implantable Ports are expected to grow at the highest CAGR, supported by their increasing use in oncology for long-term chemotherapy delivery.

Market by End-use Insights:

Hospitals & Clinics dominated the market in 2023, accounting for over 60% of revenue share. Their broad infrastructure, trained personnel, and rising surgical volume make hospitals the primary users of CVADs. Meanwhile, the Home Healthcare segment is anticipated to grow rapidly, driven by increased patient preference for in-home treatment and advances in remote monitoring technologies.

Market by Regional Insights:

North America held the largest market share in 2023, owing to its advanced healthcare infrastructure, high chronic disease prevalence, and favorable reimbursement policies. However, Asia-Pacific is forecasted to exhibit the highest growth rate through 2031, driven by rising healthcare investments, increasing medical tourism, and growing demand for cost-effective vascular access solutions.

Competitive Scenario:

Key players in the Global Central Vascular Access Devices Market include:

Becton, Dickinson and Company

Teleflex Incorporated

B. Braun Melsungen AG

AngioDynamics, Inc.

Smiths Medical

Cook Medical

ICU Medical, Inc.

Vygon Group

Medtronic plc

Edwards Lifesciences Corporation

These companies are focusing on R&D, new product launches, and strategic partnerships to strengthen their market footprint. For instance:

In 2024, BD launched a new line of antimicrobial-coated central lines designed to significantly reduce catheter-related infections.

Teleflex expanded its Arrow® brand portfolio with advanced PICCs integrated with pressure sensors for improved patient monitoring.

ICU Medical completed the acquisition of a vascular access start-up in 2023 to broaden its offering of home infusion therapy solutions.

Scope of Work – Global Central Vascular Access Devices Market

Report Metric Details

Market Size (2023) USD 4.1 billion

Projected Market Size (2031) USD 6.9 billion

CAGR (2023–2031) 6.2%

Market Segments System Type (PICC, CVC, Implantable Ports), End-use (Hospitals, Home Care)

Growth Drivers Chronic disease prevalence, technological advancements

Opportunities Expansion in emerging markets, home infusion therapy trends

Key Market Developments:

2023: Smiths Medical introduced a simplified CVAD insertion kit targeting low-resource settings, increasing accessibility and safety.

2024: Cook Medical secured FDA approval for its next-gen antimicrobial tunneled catheter for long-term use in cancer and renal patients.

2025: Medtronic launched a collaborative project with leading hospitals in Asia-Pacific to pilot AI-assisted CVAD placement technology.

FAQs:

What is the current market size of the Global Central Vascular Access Devices Market?

The market was valued at USD 4.1 billion in 2023.

What is the major growth driver of the Global Central Vascular Access Devices Market?

The rising incidence of chronic diseases and growing demand for long-term intravenous therapies.

Which is the largest region during the forecast period in the Global Central Vascular Access Devices Market?

North America holds the largest market share due to advanced infrastructure and high adoption rates.

Which segment accounted for the largest market share in the Global Central Vascular Access Devices Market?

The PICC segment led the market by system type in 2023.

Who are the key market players in the Global Central Vascular Access Devices Market?

Major players include Becton Dickinson, Teleflex, Smiths Medical, AngioDynamics, and ICU Medical.